XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 1 filers reported holding XENON PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,730 | -96.8% | 197 | -96.4% | 0.00% | -100.0% |
Q2 2023 | $212,674 | +1181422.2% | 5,524 | +981.0% | 0.01% | +600.0% |
Q1 2023 | $18 | -82.2% | 511 | -80.0% | 0.00% | -75.0% |
Q4 2022 | $101 | -99.9% | 2,552 | -39.2% | 0.00% | +100.0% |
Q3 2022 | $151,000 | +243.2% | 4,200 | +187.3% | 0.00% | +100.0% |
Q2 2022 | $44,000 | 0.0% | 1,462 | 0.0% | 0.00% | – |
Q1 2022 | $44,000 | +120.0% | 1,462 | +126.3% | 0.00% | – |
Q4 2021 | $20,000 | 0.0% | 646 | -50.8% | 0.00% | -100.0% |
Q3 2021 | $20,000 | +185.7% | 1,313 | +237.5% | 0.00% | – |
Q2 2021 | $7,000 | 0.0% | 389 | -4.0% | 0.00% | – |
Q1 2021 | $7,000 | -66.7% | 405 | -70.0% | 0.00% | -100.0% |
Q4 2020 | $21,000 | +162.5% | 1,348 | +89.3% | 0.00% | – |
Q3 2020 | $8,000 | -50.0% | 712 | -50.9% | 0.00% | -100.0% |
Q1 2020 | $16,000 | -75.4% | 1,450 | -71.0% | 0.00% | -80.0% |
Q4 2019 | $65,000 | +140.7% | 5,006 | +66.8% | 0.01% | +150.0% |
Q3 2019 | $27,000 | +42.1% | 3,002 | +60.5% | 0.00% | +100.0% |
Q1 2019 | $19,000 | +850.0% | 1,870 | +608.3% | 0.00% | – |
Q4 2018 | $2,000 | +100.0% | 264 | +164.0% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 100 | -69.2% | 0.00% | – |
Q3 2017 | $1,000 | -90.9% | 325 | -91.1% | 0.00% | -100.0% |
Q2 2017 | $11,000 | +37.5% | 3,655 | +266.6% | 0.00% | 0.0% |
Q3 2016 | $8,000 | +33.3% | 997 | +12.5% | 0.00% | 0.0% |
Q2 2016 | $6,000 | -64.7% | 886 | -62.2% | 0.00% | -66.7% |
Q1 2016 | $17,000 | +70.0% | 2,344 | +84.7% | 0.00% | +50.0% |
Q4 2015 | $10,000 | +25.0% | 1,269 | +35.7% | 0.00% | +100.0% |
Q3 2015 | $8,000 | +700.0% | 935 | +835.0% | 0.00% | – |
Q2 2015 | $1,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |